| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.16 | 2e-05 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-05 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.17 | 0.0001 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0001 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0005 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0006 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | -0.19 | 0.0007 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0008 |